Gemabank (IMCB, MOEX: GEMA) shareholders voted in absentia to pay dividends of RUB 5 per ordinary share. The record date was September 29, 2025.
IMCB is part of Artgen Biotech Group (MOEX: ABIO). Gemabank is a biotechnology company specializing in personal stem cell banking and the development of gene therapy drugs for treating blood and immune system diseases.